139 related articles for article (PubMed ID: 15033094)
1. [Degree of understanding, treatment and control of hypertension, hypercholesterolemia and diabetes mellitus in the general adult population].
Pineda Cuenca M; Custardoy Olavarrieta J; Ortín Arróniz JM; Cano Montoro JG; Andreu Ruiz MT; Grau C
Aten Primaria; 2004 Mar; 33(5):254-60. PubMed ID: 15033094
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence study of cardiovascular risk factors in a health area].
Pineda Cuenca M; Custardoy Olavarrieta J; Andreu Ruiz MT; Ortín Arróniz JM; Cano Montoro JG; Medina Ferrer E;
Aten Primaria; 2002 Sep; 30(4):207-13. PubMed ID: 12237025
[TBL] [Abstract][Full Text] [Related]
3. Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.
Omboni S; Carabelli G; Ghirardi E; Carugo S
Vasc Health Risk Manag; 2013; 9():177-85. PubMed ID: 23662063
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk factors and cardiovascular diseases in patients with moderate to severe psoriasis under systemic treatment. PSO-RISK, descriptive study.
Vanaclocha F; Belinchón I; Sánchez-Carazo JL; Rivera R; Carrascosa JM; Cea-Calvo L; Juliá B; Puig L
Eur J Dermatol; 2014; 24(6):662-9. PubMed ID: 25333326
[TBL] [Abstract][Full Text] [Related]
5. [PREVENCAT study: control of cardiovascular risk in primary care].
Alvarez-Sala LA; Suárez C; Mantilla T; Franch J; Ruilope LM; Banegas JR; Barrios V;
Med Clin (Barc); 2005 Mar; 124(11):406-10. PubMed ID: 15799845
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: a cross-sectional study.
Amadi C; Lawal F; Ajiboye W; Agbim R; Mbakwem A; Ajuluchukwu J; Oke DA
Int J Clin Pharm; 2020 Dec; 42(6):1469-1479. PubMed ID: 32960427
[TBL] [Abstract][Full Text] [Related]
7. Treating hypertension to reduce cardiovascular risk: a Korean perspective.
Kim KI; Kim CH
Clin Ther; 2012 Jul; 34(7):1559-68. PubMed ID: 22704810
[TBL] [Abstract][Full Text] [Related]
8. Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseases.
Ruiz-García A; Arranz-Martínez E; García-Álvarez JC; Morales-Cobos LE; García-Fernández ME; de la Peña-Antón N; Martín Calle MC; Díez Pérez MC; Montero Costa A; Palacios Martínez D; García Villasur MP; García Granado MAD; Lorenzo Borda MS; Cique Herráinz JA; Marañón Henrich N; Zarzuelo Martín N; Baltuille Aller MDC; Casaseca Calvo TF; Arribas Álvaro P; Macho Del Barrio AI; Moreno Fernández JC; Ribot Catalá C; Capitán Caldas M; Ciria de Pablo C; Sanz Velasco C; Simonaggio Stancampiano P; Vargas-Machuca Cabañero C; Sarriá Sánchez MT; Gómez Díaz E; Sanz Pozo B; Rodríguez de Mingo E; Cabello Igual MP; Rico Pérez MR; Migueláñez Valero A; Alcaraz Bethencourt A; Zafra Urango C; Chao Escuer P; Redondo de Pedro S; Escamilla Guijarro N; López Uriarte B; Rivera Teijido M;
Clin Investig Arterioscler; 2018; 30(5):197-208. PubMed ID: 29980384
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics and cardiovascular events in a general population included in the RICARTO (RIesgo CARdiovascular TOledo) study: Data from the first 1,500 individuals included in the study].
Rodríguez-Roca GC; Segura-Fragoso A; Villarín-Castro A; Alonso-Moreno FJ; Rodríguez-Padial L; Rodríguez-García ML; Fernández-Conde JA; Rojas-Martelo GA; Menchén-Herreros A; Escobar-Cervantes C; Fernández-Martín J; Artigao-Rodenas LM; Carbayo-Herencia JA; Hernández-Moreno J;
Semergen; 2018 Apr; 44(3):180-191. PubMed ID: 28869129
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care.
Verhave JC; Troyanov S; Mongeau F; Fradette L; Bouchard J; Awadalla P; Madore F
Clin J Am Soc Nephrol; 2014 Apr; 9(4):713-9. PubMed ID: 24458079
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk prevalence, awareness, treatment, and control from 1998 to 2007 in Koreans.
Lee K
Asia Pac J Clin Nutr; 2010; 19(2):261-5. PubMed ID: 20460242
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of obesity, diabetes, hypertension, hypercholesterolemia and metabolic syndrome in over 50-year-olds in Sanlúcar de Barrameda, Spain].
López Suárez A; Elvira González J; Beltrán Robles M; Alwakil M; Saucedo JM; Bascuñana Quirell A; Barón Ramos MA; Fernández Palacín F
Rev Esp Cardiol; 2008 Nov; 61(11):1150-8. PubMed ID: 19000490
[TBL] [Abstract][Full Text] [Related]
13. [Trends in obesity, diabetes mellitus, hypertension and hypercholesterolemia in Spain (1997-2003)].
Basterra-Gortari FJ; Bes-Rastrollo M; Seguí-Gómez M; Forga L; Martínez JA; Martínez-González MA
Med Clin (Barc); 2007 Sep; 129(11):405-8. PubMed ID: 17927933
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolaemia among adults in Dande municipality, Angola.
Pedro JM; Brito M; Barros H
Cardiovasc J Afr; 2018 Mar/Apr 23; 29(2):73-81. PubMed ID: 29293258
[TBL] [Abstract][Full Text] [Related]
15. Trends in the prevalence and management of major metabolic risk factors for chronic disease over 20 years: findings from the 1998-2018 Korea National Health and Nutrition Examination Survey.
Kim Y; Nho SJ; Woo G; Kim H; Park S; Kim Y; Park O; Oh K
Epidemiol Health; 2021; 43():e2021028. PubMed ID: 33872481
[TBL] [Abstract][Full Text] [Related]
16. Population prevalence and control of cardiovascular risk factors: what electronic medical records tell us.
Catalán-Ramos A; Verdú JM; Grau M; Iglesias-Rodal M; del Val García JL; Consola A; Comin E;
Aten Primaria; 2014 Jan; 46(1):15-24. PubMed ID: 24325864
[TBL] [Abstract][Full Text] [Related]
17. [Factors associated with the optimum simultaneous control of diabetes, arterial hypertension and hypercholesterolemia in the diabetic population. BPC Diabetes study].
Llisterri-Caro JL; Turégano-Yedro M; Cinza-Sanjurjo S; Segura-Fragoso A; Sánchez-Sánchez B; Cubelos-Fernández N; Velilla-Zancada S; Micó-Pérez RM; Martín-Sánchez V;
Semergen; 2022; 48(4):225-234. PubMed ID: 34479796
[TBL] [Abstract][Full Text] [Related]
18. Does fitness improve the cardiovascular risk profile in obese subjects?
Halland H; Lønnebakken MT; Saeed S; Midtbø H; Cramariuc D; Gerdts E
Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):518-524. PubMed ID: 28528703
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
[TBL] [Abstract][Full Text] [Related]
20. Determinants of major cardiovascular risk factors among participants of the South Carolina WISEWOMAN program, 2009-2012.
Nahhas GJ; Daguise V; Ortaglia A; Merchant AT
Prev Chronic Dis; 2014 Sep; 11():E153. PubMed ID: 25188278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
